Results 161 to 170 of about 4,080 (215)

The Effect of Er:YAG Laser Therapy as an Adjunct to Surgical Treatment Compared to Latter Alone in Managing Medication-Related Osteonecrosis of the Jaw: A Randomised Controlled Clinical Trial. [PDF]

Int Dent J
Michalak F, Dominiak M, Kiryk J, Abd-Ul-Salam H, Grzech-Leśniak K.   +4 more
europepmc   +1 more source

Bone progression in multiple myeloma: Benefit of zoledronic acid for patients achieving at least Very Good Partial Response and prognostic value of bone turnover markers. [PDF]

Br J Haematol
Gundesen MT, Vangsted AJ, Helleberg C, Haukås E, Silkjær T, Madsen JS, Asmussen JT, Teodorescu EM, Jensen BA, Slørdahl TS, Nielsen AA, Olsen DA, Søe K, Nahi H, Waage A, Abildgaard N, Schjesvold F, Lund T.   +17 more
europepmc   +1 more source

Uncovering jaw-specific radiographic differences in medication related osteonecrosis of the jaws (MRONJ): a case-control study. [PDF]

Clin Oral Investig
Masri D, Chaushu G, Rosenfeld E, Muchnik D, Adut S, Avishai G, Ghanaiem O.   +6 more
europepmc   +1 more source

CT-Based Lesion Volume as an Independent Predictor of Surgical Recurrence in Medication-Related Osteonecrosis of the Jaw: A Multi-Center Study of 1007 Patients. [PDF]

J Clin Med
Ryu CW, Park SM, Park HS, Jung HO, Han SJ.   +4 more
europepmc   +1 more source

Platelet-Rich Fibrin in Surgical Wound Healing of Medication-Related Osteonecrosis of the Jaw: A Pilot Clinical Study. [PDF]

Int J Mol Sci
Nowak A, Rudzka A, Skrzypczak P, Osmola K, Wyganowska ML.   +4 more
europepmc   +1 more source

Quantitative Bone Assessment in Medication-Related Osteonecrosis of the Jaw Using Fractal Analysis: A Systematic Review of the Literature and Clinical Perspectives. [PDF]

Dent J (Basel)
Misiejuk A, Adamska P, Żółtowska A, Zedler A.   +3 more
europepmc   +1 more source

Actinomyces and MRONJ: A retrospective study and a literature review

Journal of Stomatology, Oral and Maxillofacial Surgery, 2021
The AAOMS in 2014 changed from BRONJ to the term Medication-Related Osteonecrosis of the Jaw (MRONJ), because of the growing number of osteonecrosis cases associated with other antiresorptive and antiangiogenic therapies. Even if the drugs involved are different, the histopathological findings are the same.
Marialuisa Valente, Christian Bacci, Gastone Zanette   +2 more
exaly   +5 more sources

Minimizing MRONJ after Tooth Extraction in Cancer Patients Receiving Bone-Modifying Agents

Journal of Clinical Medicine, 2022
Background: Medication-related osteonecrosis of the jaws (MRONJ) is a mucosal lesion of the maxillofacial region with necrotic bone exposure. MRONJ is believed to be multifactorial. Tooth extraction is debatably a risk factor for MRONJ.
Gal Avishai, Gavriel Chaushu, Daya Masri
exaly   +2 more sources

Epidemiology, etiopathogenesis, and management of MRONJ: A European multicenter study [PDF]

Journal of Stomatology, Oral and Maxillofacial Surgery
Introduction: The purpose of this European multicenter study was to describe the general characteristics and risk factors of MRONJ lesions as well as their clinical diagnosis and management at different European Oral and Maxillofacial Surgery centers, in
Paolo Boffano, Petia Pechalova, Bertin Eugénie   +2 more
exaly   +3 more sources